An analyst raised his price target on the telehealth leader. The 25% increase was considerable. News of the increase hit the headlines shortly before the market open. Jefferies prognosticator Glen ...
If you have been wondering whether Teladoc Health is a beaten down bargain or a value trap, you are not alone, and this ...
Analyst Allen Lutz of Bank of America Securities maintained a Hold rating on Teladoc (TDOC – Research Report), with a price target of $24.00. Allen Lutz has given his Hold rating due to a combination ...
Glen Santangelo, an analyst from Jefferies, assigned the Hold rating on Teladoc (TDOC – Research Report). The associated price target is $10.00. Glen Santangelo’s rating is based on a nuanced view of ...
Teladoc Health (TDOC) has drawn attention lately as its share price continues to drift from previous highs. This has prompted investors to revisit its long-term potential. The stock's recent slide has ...
Teladoc Health (TDOC) shares have traded sideways over the past week, following a period of steady declines since the start of the year. Investors are watching to see if the telemedicine provider can ...
Teladoc Health (NYSE:TDOC) is gearing up to announce its quarterly earnings on Wednesday, 2025-10-29. Here's a quick overview of what investors should know before the release. Analysts are estimating ...
StockStory.org on MSN
Teladoc and Netflix Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after markets faded the Nvidia rally in the morning session, as investors remained uncertain about future rate cuts. While the trading ...
Here are 13 Teladoc executives to know: Jason Gorevic, chief executive officer. Mr. Gorevic has served as chief executive officer since 2009. Under his leadership, Teladoc experienced significant ...
Absent of any other stock-moving news, a 25% increase in an analyst's price target for Teladoc (NYSE: TDOC) got the stock moving northward on Tuesday. It ended up closing the day almost 12% higher on ...
News of the increase hit the headlines shortly before the market open. Jefferies prognosticator Glen Santangelo now feels Teladoc is worth $10 per share, up from his previous estimation of $8. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback